| Stage | CNR | % of rev | BKV | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $1.1B | 100.00% | $466M | 100.00% | CNR ×2.45 |
| Gross profit | $252M | 22.09% | $308M | 66.14% | BKV +44.1pp |
| Operating income | $156M | 13.65% | $122M | 26.13% | BKV +12.5pp |
| Pre-tax income | $143M | 12.53% | $97M | 20.94% | BKV +8.4pp |
| Net income | $126M | 11.08% | $77M | 16.61% | BKV +5.5pp |
| Stage | CNR | BKV | Gap · A − B |
|---|---|---|---|
| Revenue | $1.1B100.00% | $466M100.00% | CNR ×2.45 |
| Gross profit | 22.09%$252M | 66.14%$308M | BKV +44.1pp |
| Operating income | 13.65%$156M | 26.13%$122M | BKV +12.5pp |
| Pre-tax income | 12.53%$143M | 20.94%$97M | BKV +8.4pp |
| Net income |
| 11.08%$126M |
| 16.61%$77M |
| BKV +5.5pp |
None
No disclosed counterparties: CNR.